ALKM – Alkame Confirms Product Development Backlog And New PURA Investment
Las Vegas, Nevada, June 15, 2021 (GLOBE NEWSWIRE) -- Alkame Holdings, Inc. (OTC PINK: ALKM) today confirmed the product development backlog and Puration, Inc. (OTC Pink: PURA) investment announced yesterday.
ALKM has a dozen companies currently in various stages of product development, and production testing prior to entering the market, and approximately another dozen onboarding as COVID restrictions ease up.
Some of the new products that have already been announced and expected to enter the market this summer are Shmellins Caramel Sauce, New & Improved EVERx CBD Sports Waters, Simple CBD Lemonades, and Humble Harvest CBD Teas, just to name a few, with many more brand announcements coming shortly.
ALKM’s West Coast Copacker, Inc. is now working in conjunction with Quencha Tea on entering the beverage sector with the development and production of a high-quality tea beverage line. The initial three delicious teas will be Original, Honey Lemon and Black Currant, each being packaged in 10oz glass bottles and exported into Hawaii to start.
PURA yesterday finalized with ALKM on the previously announced commitment for PURA to increase its investment in ALKM.
In an earlier capital investment initiative, PURA acquired a five percent interest in ALKM.
PURA is working with ALKM and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) in the development of a series of new CBD infused products. PURA’s new investment will be directed at funding ALKM to formulate the products and set up the ALKM plant for producing the products. USMJ will manage marketing of the new CBD infused products.
The investment transaction is now complete. PURA has advanced funds for ALKM to formulate products and set up the ALKM plant for producing new products. While the investment, like all investments, is at risk, PURA expects the investment to ultimately result in ALKM creating new products for PURA whereby PURA’s return will come from the sale of the new products with no long-term debt or equity impact to ALKM.
About West Coast Co Packer, Inc.
West Coast Co Packer, Inc., is a wholly owned subsidiary of Alkame Holdings, Inc. and is a specialty liquid and single-serve manufacturer, co-packer, private labeler, and contract manufacturer, and is expected to immediately complement and seamlessly integrate with Alkame's other subsidiaries including Bell Food and Beverage, Inc. Bell Food and Beverage, Inc. is a specialty natural, organic liquid-based hot and cold fill food & beverage manufacturer in glass and PET bottles and jars. To learn more about West Coast CoPacker visit .
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly owned subsidiaries manufacture products with enhanced water utilizing a proprietary technology to create products with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications by placement into several emerging business sectors, such as consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, hand sanitizers, and many other various water based treatment solutions to both new and existing business platforms.
For more information, visit .
Alkame Holdings, Inc. Investor Relations
Website:
Email:
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Onward & Upward,
Robert K. Eakle - CEO
Office (702) 273-9714
Facility (503) 495-1425
Cell (949) 903-0182
SOURCE: Alkame Holdings, Inc.
